Liver Liquid Biopsy
Grant Amount: NIS 3.6 million
About the Project
This project takes the team’s recently developed minimally-invasive “liquid biopsy” and extends it to address clinical needs, focusing on two liver diseases: Nonalcoholic fatty liver disease (NAFLD) and acute post-transplantation liver rejection. The researchers will recruit patient cohorts and perform detailed molecular analysis of repeated samples of plasma and liver biopsies. They will analyze them using advanced AI methods to determine how information from patients can impact the diagnosis and treatment in these patients. 
Research Team
Prof. Nir Friedman
School of Computer Science and Engineering, Hebrew University-Edmond J. Safra Campus
Prof. Eithan Galun
Gene Therapy Institute, Hadassah Medical Center
More Projects Funded